Evidence map›Paper›PMID 37633957›Full record

ArticleScientific reports2023

Targeted gene expression profiling for accurate endometrial receptivity testing.

Alvin Meltsov, Merli Saare, Hindrek Teder, Priit Paluoja, Riikka K Arffman, Terhi Piltonen, Piotr Laudanski, Mirosław Wielgoś, Luca Gianaroli, Mariann Koel and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Cell type and region-specific transcriptional changes in the endometrium of women with RIF identify potential treatment targets.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. From DNA to Big Data: NGS Technologies and Their Applications.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  17. Article
  18. Article
  19. The Role of the Endometrium in Implantation: A Modern View.International journal of molecular sciences · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 5 countries.

Alvin Meltsov *Competence Centre On Health Technologies, 50411, Tartu, Estonia.ORCID http://orcid.org/0000-0002-9058-0779
Merli Saare *Competence Centre On Health Technologies, 50411, Tartu, Estonia. merli.saare@ut.ee.ORCID http://orcid.org/0000-0003-0221-2093
Hindrek TederCompetence Centre On Health Technologies, 50411, Tartu, Estonia.ORCID http://orcid.org/0000-0001-6608-7979
Priit PaluojaCompetence Centre On Health Technologies, 50411, Tartu, Estonia.ORCID http://orcid.org/0000-0002-2016-661X
Riikka K ArffmanDepartment of Obstetrics and Gynecology, PEDEGO Research Unit, Medical Research Center, Oulu University Hospital, University of Oulu, FI-90014, Oulu, Finland.ORCID http://orcid.org/0000-0003-3277-9293
Terhi PiltonenDepartment of Obstetrics and Gynecology, PEDEGO Research Unit, Medical Research Center, Oulu University Hospital, University of Oulu, FI-90014, Oulu, Finland.ORCID http://orcid.org/0000-0002-9921-7300
Piotr LaudanskiOviklinika Infertility Center, 01-377, Warsaw, Poland.ORCID http://orcid.org/0000-0001-8955-8198
Mirosław WielgośMedical Faculty, Lazarski University, Warsaw, Poland.ORCID http://orcid.org/0000-0003-2581-3668
Luca GianaroliSISMeR, Reproductive Medicine Institute, 40138, Bologna, Italy.ORCID http://orcid.org/0000-0002-6077-9840
Mariann KoelInstitute of Genomics, University of Tartu, 51010, Tartu, Estonia.ORCID http://orcid.org/0000-0001-8567-7296
Maire PetersCompetence Centre On Health Technologies, 50411, Tartu, Estonia.ORCID http://orcid.org/0000-0003-2063-242X
Andres SalumetsCompetence Centre On Health Technologies, 50411, Tartu, Estonia.ORCID http://orcid.org/0000-0002-1251-8160
Kaarel KrjutškovCompetence Centre On Health Technologies, 50411, Tartu, Estonia.ORCID http://orcid.org/0000-0003-1297-1464
Priit PaltaCompetence Centre On Health Technologies, 50411, Tartu, Estonia.ORCID http://orcid.org/0000-0001-9320-7008
Competence Centre on Health Technologies (Estonia) · EEOulu University Hospital · FIKarolinska University Hospital · SEMaastricht University · NLMedical University of Warsaw · PLUczelnia Łazarskiego · PLUniversity of Helsinki · FIUniversity of Tartu · EE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Expressional profiling of the endometrium enables the personalised timing of the window of implantation (WOI). This study presents and evaluates a novel analytical pipeline based on a TAC-seq (Targeted Allele Counting by sequencing) method for endometrial dating. The expressional profiles were clustered, and differential expression analysis was performed on the model development group, using 63 endometrial biopsies spanning over proliferative (PE, n = 18), early-secretory (ESE, n = 18), mid-secretory (MSE, n = 17) and late-secretory (LSE, n = 10) endometrial phases of the natural cycle. A quantitative predictor model was trained on the development group and validated on sequenced samples from healthy women, consisting of 52 paired samples taken from ESE and MSE phases and five LSE phase samples from 31 individuals. Finally, the developed test was applied to 44 MSE phase samples from a study group of patients diagnosed with recurrent implantation failure (RIF). In validation samples (n = 57), we detected displaced WOI in 1.8% of the samples from fertile women. In the RIF study group, we detected a significantly higher proportion of the samples with shifted WOI than in the validation set of samples from fertile women, 15.9% and 1.8% (p = 0.012), respectively. The developed model was evaluated with an average cross-validation accuracy of 98.8% and an accuracy of 98.2% in the validation group. The developed beREADY screening model enables sensitive and dynamic detection of selected transcriptome biomarkers, providing a quantitative and accurate prediction of endometrial receptivity status.

Indexed as

Gene Expression ProfilingTranscriptomeAllelesEndometriumFemaleHumansMicroarray Analysis

Identifiers

PMID37633957
PMCPMC10460380
OpenAlexW4386191762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.